PeerJ. 2017 Mar 16;5:e3105. doi: 10.7717/peerj.3105. eCollection 2017.
Evaluation of procedures for typing of group B .
PeerJ
Hans-Christian Slotved, Steen Hoffmann
Affiliations
Affiliations
- Neisseria and Streptococcus Reference Laboratory, Department of Microbiology and Infection Control, Statens Serum Institut , Copenhagen , Denmark.
PMID: 28321367
PMCID: PMC5357338 DOI: 10.7717/peerj.3105
Abstract
BACKGROUND: This study evaluates two procedures for typing of
METHODS: A total of 616 clinical GBS isolates from 2010 to 2014 were tested with both a latex test and the LP test. Among these, 66 isolates were genotyped by PCR, including 41 isolates that were phenotypically NT.
RESULTS: The latex test provided a serotype for 83.8% of the isolates (95% CI [80.7-86.6]) compared to 87.5% (95% CI [84.6-90.0]) obtained by the LP method. The two assays provided identical capsular identification for all sero-typeable isolates (excluding NT isolates). The PCR assay provided a genotype designation to the 41 isolates defined as phenotypically NT isolates.
DISCUSSION: We found that the latex test showed a slightly lower identification percentage than the LP test. Our recommendation is to use the latex agglutination as the routine primary assay for GBS surveillance, and then use the more labour intensive precipitation test on the NT isolates to increase the serotyping rate. A genotype could be assigned to all the phenotypically NT isolates, however, as a consequence genotyping will overestimate the coverage from possible future capsular polysaccharide based GBS vaccines.
Keywords: Group B Streptococcus; Lancefield precipitation; Latex test; Serotyping
Conflict of interest statement
The authors declare there are no competing interests.
References
- Trop Med Int Health. 2015 Nov;20(11):1516-1524 - PubMed
- Vaccine. 2013 Aug 28;31 Suppl 4:D7-12 - PubMed
- J Microbiol Methods. 2010 Feb;80(2):212-4 - PubMed
- J Microbiol Methods. 2015 Jan;108:31-5 - PubMed
- Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1071-7 - PubMed
- BMC Pediatr. 2016 Jul 07;16:82 - PubMed
- Vaccine. 2016 Jun 3;34(26):2876-9 - PubMed
- Vaccine. 2013 Aug 28;31 Suppl 4:D20-6 - PubMed
- J Clin Microbiol. 2007 Sep;45(9):2929-36 - PubMed
- J Clin Microbiol. 2002 May;40(5):1882-3 - PubMed
- J Clin Microbiol. 2007 Jun;45(6):1985-8 - PubMed
- J Clin Microbiol. 2003 Sep;41(9):4445-7 - PubMed
- Clin Microbiol Infect. 2009 Dec;15(12):1182-5 - PubMed
- J Clin Microbiol. 2016 May;54(5):1388-90 - PubMed
- J Clin Microbiol. 2013 Feb;51(2):503-7 - PubMed
- J Clin Microbiol. 2011 Apr;49(4):1475-82 - PubMed
- Infect Dis (Lond). 2016;48(5):386-91 - PubMed
Publication Types